Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diclofenac, Baclofen, Orphenadrine, and Bupivacaine for Hand Osteoarthritis
NCT02485145Phase 1Unknown
- Sponsor
- Transdermal Therapeutics
- Start
- Jul 2015
- Primary completion
- Dec 2015
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of diclofenac, baclofen, orphenadrine and bupivacaine in osteoarthritis (OA) (2 arms), sponsored by Transdermal Therapeutics. Primary endpoints: Visual Analog Scale at 28 days, Australia/Canadian Osteoarthritis Index at 28 days and 1 more. Status: unknown.
02
Drugs
diclofenacbaclofenorphenadrinebupivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02485145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485145.